Search research articles
Contact Us
Filters
Showing results (101-110 of 208) with videos related to
Page
of 21
Sort By:
Human Pathology
|
August 28, 2002
Expression of mos in astrocytic tumors and its potential role in neoplastic progression
Branko Perunovic, Athanasios Athanasiou, Robert D Quilty, et al.
Brain : a Journal of Neurology
|
April 12, 2003
Unilateral subthalamotomy in the treatment of Parkinson's disease
Nikunj K Patel, Peter Heywood, Karen O'Sullivan, et al.
Journal of Neuroscience Methods
|
October 2, 2007
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid
James Scott Miners, Marcel M Verbeek, Marcel Olde Rikkert, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 28, 2021
Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease
Lindsey Sinclair, Jake Brenton, Alan King Lun Liu, et al.
Neuropathology and Applied Neurobiology
|
January 6, 2015
Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia
Emma L Ashby, James S Miners, Sathish Kumar, et al.
Brain Pathology (Zurich, Switzerland)
|
March 28, 2008
Abeta-degrading enzymes in Alzheimer's disease
James Scott Miners, Shabnam Baig, Jennifer Palmer, et al.
Journal of Neurochemistry
|
October 10, 2012
Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation
Jonathon Hull, Maya El Hindy, Patrick G Kehoe, et al.
Journal of Neuropathology and Experimental Neurology
|
October 6, 2006
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
James Scott Miners, Zoë Van Helmond, Katy Chalmers, et al.
Neuroreport
|
April 27, 2004
APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease
Katy A Chalmers, Doris Culpan, Patrick G Kehoe, et al.
Journal of Alzheimer'S Disease : JAD
|
January 11, 2012
Clusterin mRNA and protein in Alzheimer's disease
Shabnam Baig, Laura E Palmer, Michael J Owen, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 208) with videos related to
Sort By:
Page
of 21
Human Pathology
|
August 28, 2002
Expression of mos in astrocytic tumors and its potential role in neoplastic progression
Branko Perunovic, Athanasios Athanasiou, Robert D Quilty, et al.
Brain : a Journal of Neurology
|
April 12, 2003
Unilateral subthalamotomy in the treatment of Parkinson's disease
Nikunj K Patel, Peter Heywood, Karen O'Sullivan, et al.
Journal of Neuroscience Methods
|
October 2, 2007
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid
James Scott Miners, Marcel M Verbeek, Marcel Olde Rikkert, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
December 28, 2021
Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease
Lindsey Sinclair, Jake Brenton, Alan King Lun Liu, et al.
Neuropathology and Applied Neurobiology
|
January 6, 2015
Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia
Emma L Ashby, James S Miners, Sathish Kumar, et al.
Brain Pathology (Zurich, Switzerland)
|
March 28, 2008
Abeta-degrading enzymes in Alzheimer's disease
James Scott Miners, Shabnam Baig, Jennifer Palmer, et al.
Journal of Neurochemistry
|
October 10, 2012
Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation
Jonathon Hull, Maya El Hindy, Patrick G Kehoe, et al.
Journal of Neuropathology and Experimental Neurology
|
October 6, 2006
Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy
James Scott Miners, Zoë Van Helmond, Katy Chalmers, et al.
Neuroreport
|
April 27, 2004
APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease
Katy A Chalmers, Doris Culpan, Patrick G Kehoe, et al.
Journal of Alzheimer'S Disease : JAD
|
January 11, 2012
Clusterin mRNA and protein in Alzheimer's disease
Shabnam Baig, Laura E Palmer, Michael J Owen, et al.
Page
of 21